OncoGenex Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Net Operating Cash Flow | (5.5) | (5.3) | (5.8) | (3.5) | (4.6) |
| Net Investing Cash Flow | (6.4) | 16.4 | 10.0 | 3.2 | (8.7) |
| Net Financing Cash Flow | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Net Change in Cash | (11.9) | 11.1 | 4.3 | (0.3) | (13.2) |
| Depreciation & Amortization | 0.4 | 0.3 | 0.2 | 0.1 | 0.0 |
| Capital Expenditures | (0.1) | (0.1) | (0.8) | (0.2) | (0.4) |
| Cash Dividends Paid | -- | -- | -- | -- | -- |
This data is provided as per license from EDGAR Online
